Media and News

See what’s new in the fight against AMR.

Additional News Articles

Read More
Shortened treatment benefits some with pre-extensively drug-resistant TB, but not all
A randomized trial finds that a 6- to 9-month regimen of bedaquiline, delamanid, linezolid, and clofazimine worked better in pre-XDR TB patients with limited disease.
Read More
Read More
Study hints doxyPEP use coincides with rise in tetracycline-resistant gonorrhea in US
A genomic analysis finds the percentage of US gonorrhea isolates carrying tetracycline resistance genes rose from 10% in 2020 to more than 30% in 2024.
Read More
Read More
In 2 trials, less toxic TB antibiotics show promise
The results of 2 phase 2b trials suggest sutezolid and delpazolid could provide safer alternatives to linezolid in shorter drug regimens for drug-resistant TB.
Read More
Read More
First-trimester antibiotic use for urinary tract infections tied to more congenital malformations
A study of more than 70,000 US pregnancies finds that use of trimethoprim-sulfamethoxazole for UTIs during the first trimester was associated with increased risk of congenital malformations.
Read More

Share Your Story and Become an Antimicrobial Resistance Fighter